Last week, the Philippine government announced that Health Secretary Francisco Duque III, Chancellor Teodoro Locsin Jr. and a representative of the president’s workplace held separate talks with the Russian embassy and us pharmaceutical company. Pfizer, to talk about arrangements that would make certain “vaccines suitable and good enough for the population”. It moves me like an act of balance: one from the East, the other from the West. That way, we might not offend or disappoint our lifelong friends until we could bond with a new, not very familiar neighbor who has presented himself generously to help in the fight against COVID-19. The president himself volunteered to participate in the clinical trials of Sputnik V. How can we not take the use of a Russian vaccine seriously?Let me remind our readers of what happened to Sputnik V.
Last Friday, The Lancet, the world’s leading independent medical journal with foreign and political policy of all facets of human health, published the effects of early russian vaccine trials, which showed that Sputnik V produced an anti-body reaction in all. any serious adverse effects.
In a pandemic caused by coronavirus with international deaths close to the million-brand mark, it is unsure what regulators will conform to as evidence of an effective and safe vaccine, as regulators in other countries may have other standards. ordered states to prepare to distribute a possible vaccine opposed to COVID-19 until 1 November. The call for the vaccine or the trials it had undergone was not mentioned, but a letter from the Director of the Robert Redfield Centers for Disease Control and Prevention called for the acceleration of programs for those distribution facilities. On August 28, the U. S. Food and Drug Administration issued an emergency use authorization to allow the use of the modest Remdesivir product for the remedy of adults and young people hospitalized with COVID-19. Remdesivir is produced through Gilead Sciences Inc. , a U. S. biopharmaceutical antiviral drug company, but it is not a vaccine. It does not have FDA approval.
Several vaccines are being developed through Western pharmaceutical companies: one of the applicants is a product of partnership between the French company Sanofi and the British company GSK; another is an assignment from the University of Oxford with British pharmaceutical giant AstraZeneca which, according to officials, will soon be available.
According to some reports, the United States, the United Kingdom, the European Union, Canada and Japan have already reserved gigantic quantities of experimental vaccines and even before the clinical trials of those vaccines ended, those countries had almost taken over the initial supply. Richard Hatchett, leader of the Coalition for Innovations in Epidemic Preparedness, is concerned: “We want to convince world leaders that as soon as a vaccine is available in limited quantities, it will have to be shared globally. “
[email protected]
The Inquirer Foundation supports our health care leaders and accepts donations of money to deposit into the Gold Bank’s (BDO) checking account 007960018860 or to donate through PayMaya via this link.
We use cookies for the most productive enjoyment on our website. By continuing, you are satisfied with our use of cookies. For more information, click this link.